Literature DB >> 29960278

Pulmonary tuberculosis in a male with silicosis.

Marcin Skowroński1, Anna Halicka, Aleksander Barinow-Wojewódzki.   

Abstract

Silicosis, a preventable occupational lung disease, is associated with various diseases, including tuberculosis (TB). There is an increased lifelong risk for lung tuberculosis even if exposure to silica dust ceases. That association contributes in a large extent to very high rates of tuberculosis in countries with poor TB and silica exposure control. We report a case of a male with a prior diagnosis of silicosis who was diagnosed with and treated for TB. Anti-tuberculous treatment was extended due to a positive sputum smear in the six th month of treatment. However, the culture of the sputum was negative. This case report highlights the value of thorough screening for tuberculosis in silicotic patients. The clinical management of these patients may be challenging due to frequent overlapping radiological features and uncertain results of TB treatment.

Entities:  

Keywords:  dust; exposure; occupational; silicosis; tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 29960278     DOI: 10.5603/ARM.2018.0019

Source DB:  PubMed          Journal:  Adv Respir Med        ISSN: 2451-4934


  2 in total

1.  Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania.

Authors:  Peter M Mbelele; Emmanuel A Mpolya; Elingarami Sauli; Bariki Mtafya; Nyanda E Ntinginya; Kennedy K Addo; Katharina Kreppel; Sayoki Mfinanga; Patrick P J Phillips; Stephen H Gillespie; Scott K Heysell; Wilber Sabiiti; Stellah G Mpagama
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  A rapid point of care CC16 kit for screening of occupational silica dust exposed workers for early detection of silicosis/silico-tuberculosis.

Authors:  Shyam Sundar Nandi; Upendra P Lambe; Kamalesh Sarkar; Sonali Sawant; Jagadish Deshpande
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.